Hjem › Akut myelogen leukemi › Connecticut › Bridgeport
Kliniske studier for Akut myelogen leukemi i Bridgeport, CT
12 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Bridgeport (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi unna
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Stony Brook University Medical Center, Stony Brook · 18 mi unna
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi unna
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi unna
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi unna
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi unna
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekruttererFase 3
- Stony Brook University Medical Center, Stony Brook · 18 mi unna
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Stony Brook University Medical Center, Stony Brook · 18 mi unna
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekruttererFase 1
- Stony Brook Cancer Center, Stony Brook · 18 mi unna
Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)
RekruttererObservasjonsstudie
- Stony Brook Cancer Center, Stony Brook · 18 mi unna
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- Stony Brook University Hospital, Stony Brook · 18 mi unna
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekruttererFase 1
- Stony Brook University Hospital, Stony Brook · 18 mi unna
Akut myelogen leukemi-studier i andre byer
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Seattle, WA41 studier
- Baldwin Park, CA40 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Atlanta, GA31 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
Andre studier i Bridgeport
- Brystkreft21 studier
- Ikke-småcellet lungekreft14 studier
- Lungekreft13 studier
- Kardiovaskulær sykdom9 studier
- Kreft (alle typer)8 studier
- Plateepitelcancer i hode og hals8 studier
- Metastatisk kreft7 studier
- Hjertesvikt7 studier
- Hjaneurisme6 studier
- Multipelt myelom6 studier
- Prostatakreft6 studier
- Eggstokkreft5 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.